Skip to Content

669 Results Found

  • Article
  • Open Access
4 Citations
3,154 Views
10 Pages

Concomitant Bladder Tumor Is a Risk Factor for Bladder Recurrence but Not Upper Tract

  • Kang Liu,
  • Hongda Zhao,
  • Mario Alvarez-Maestro,
  • Stavros Gravas and ,
  • Koen Van Renterghem,
  • Guohua Zeng,
  • Chi-Fai Ng,
  • Pilar Laguna,
  • Jeremy Yuen-Chun Teoh and
  • Jean De La Rosette
  • + 5 authors+ 0 author

28 November 2022

Objective: To evaluate the clinical outcomes of UTUC patients with or without concurrent bladder tumor. Design, Setting, and Participants: The Clinical Research Office of the Endourology Society-Urothelial Carcinomas of the Upper Tract (CROES-UTUC) R...

(This article belongs to the Topic Real-Time Monitoring for Improving Cancer Diagnosis and Prognosis)
  • Article
  • Open Access
1,647 Views
15 Pages

Recurrence Rate After Post-Operative Two-Hour Continuous Bladder Irrigation for Primary Non-Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study

  • Patrick Sterner,
  • Sanna Gimbergsson,
  • Markus Johansson,
  • Farhood Alamdari and ,
  • Amir Sherif,
  • Abbas Chabok and
  • Johan Styrke
  • + 2 authors+ 0 author

24 March 2026

Background: High recurrence rates for non-muscle-invasive bladder cancer (NMIBC) remain a clinical challenge. Recommended post-operative treatments are underutilized, highlighting the need for alternative strategies. Given the variability in bladder...

(This article belongs to the Special Issue Urological Cancer: Clinical Advances in Personalized Therapy)
  • Review
  • Open Access
14 Citations
5,673 Views
17 Pages

The Roles of miRNAs in Predicting Bladder Cancer Recurrence and Resistance to Treatment

  • Sanjna Das,
  • Joshua Hayden,
  • Travis Sullivan and
  • Kimberly Rieger-Christ

Bladder cancer (BCa) is associated with significant morbidity, with development linked to environmental, lifestyle, and genetic causes. Recurrence presents a significant issue and is managed in the clinical setting with intravesical chemotherapy or i...

(This article belongs to the Special Issue Non-coding RNAs and Human Diseases: Current Status and Future Perspectives)
  • Article
  • Open Access
5 Citations
2,528 Views
8 Pages

Low Preoperative Lymphocyte-to-Monocyte Ratio Is Predictive of the 5-Year Recurrence of Bladder Tumor after Transurethral Resection

  • Kyungmi Kim,
  • Jihion Yu,
  • Jun-Young Park,
  • Sungwoon Baek and ,
  • Jai-Hyun Hwang,
  • Woo-Jong Choi and
  • Young-Kug Kim
  • + 2 authors+ 0 author

23 September 2021

Many studies have investigated the prognostic significance of peripheral blood parameters—including lymphocyte-to-monocyte ratio (LMR)—in several cancers in recent decades. We evaluated the prognostic factors for five-year tumor recurrence after the...

(This article belongs to the Special Issue Cancer Biomarker Research and Personalized Medicine)
  • Article
  • Open Access
8 Citations
3,819 Views
20 Pages

Association of SNPs in the PAI1 Gene with Disease Recurrence and Clinical Outcome in Bladder Cancer

  • Kaoru Murakami,
  • Hideki Furuya,
  • Kanani Hokutan,
  • Steve Goodison and ,
  • Ian Pagano,
  • Runpu Chen,
  • Cheng-Huang Shen,
  • Michael W. Y. Chan,
  • Chi Fai Ng and
  • Charles J. Rosser
  • + 13 authors+ 8 authors

Purpose: Bladder cancer (BCa) is one of the most common cancer types worldwide and is characterized by a high rate of recurrence. In previous studies, we and others have described the functional influence of plasminogen activator inhibitor-1 (PAI1) i...

(This article belongs to the Special Issue Molecular Biomarkers in Cancer and Their Applications)
  • Article
  • Open Access
5 Citations
2,172 Views
9 Pages

Impact of Pre-Operative Ureteroscopy on Bladder Recurrence Following Nephroureterectomy for UTUC

  • Chris Ho-Ming Wong,
  • Ivan Ching-Ho Ko,
  • David Ka-Wai Leung,
  • Kang Liu and ,
  • Hongda Zhao,
  • Mario Alvarez-Maestro,
  • Maria del Pilar Laguna Pes,
  • Jean de la Rosette and
  • Jeremy Yuen-Chun Teoh
  • + 4 authors+ 0 author

28 July 2024

(1) Introduction: Diagnostic ureteroscopy (URS) is an important component in the workup of upper tract urothelial carcinoma (UTUC). Whether URS was associated with increased recurrence in the bladder was not fully concluded. The current study aimed t...

(This article belongs to the Special Issue Advances in Management of Urothelial Cancer)
  • Article
  • Open Access
7 Citations
3,634 Views
18 Pages

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence, and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma

  • Keisuke Shigeta,
  • Kazuhiro Matsumoto,
  • Nobuyuki Tanaka,
  • Shuji Mikami and ,
  • Takeo Kosaka,
  • Yota Yasumizu,
  • Toshikazu Takeda,
  • Ryuichi Mizuno,
  • Eiji Kikuchi and
  • Mototsugu Oya
  • + 5 authors+ 0 author

To evaluate biological characteristics and transitions of upper tract urothelial carcinoma (UTUC) through metachronous bladder tumors after radical nephroureterectomy (RNU), we conducted immunohistochemical (IHC) staining of tumor specimens of UTUC t...

(This article belongs to the Special Issue Bladder Cancer: Molecular Advances in Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
1 Citations
2,261 Views
10 Pages

The Impact of the Localization of Metastasis in Bladder Cancer Patients with Recurrence After Cystectomy

  • Mads Aamand,
  • Simone Buchardt Brandt,
  • Rikke Vilsbøll Milling and
  • Jørgen Bjerggaard Jensen

3 March 2025

Background/Objectives: The aim of this study is to assess the prognostic implications of metastatic anatomical location in patients with recurrent bladder cancer (BC) after cystectomy. Methods: The study is a retrospective cohort study. All data were...

(This article belongs to the Section Cancer Metastasis)
  • Article
  • Open Access
493 Views
15 Pages

Preoperative Platelet-to-Lymphocyte Ratio as a Predictor of Recurrence and Recurrence-Free Survival in Non-Muscle-Invasive Bladder Cancer Across Different Intravesical Therapies

  • Muhammet İhsan Öztürk,
  • Musa Ekici,
  • Cemil Aydın,
  • Mustafa Serdar Çağlayan and ,
  • Mücahit Doğan and
  • Mehmet Murat Baykam
  • + 1 author+ 0 author

3 July 2026

Background/Objectives: Non-muscle invasive bladder cancer (NMIBC) is characterized by high recurrence rates despite appropriate treatment and surveillance. Identifying inexpensive and readily available biomarkers capable of improving risk stratificat...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
6 Citations
4,157 Views
15 Pages

Impact of Occupational Exposures and Genetic Polymorphisms on Recurrence and Progression of Non-Muscle-Invasive Bladder Cancer

  • Angela Carta,
  • Sofia Pavanello,
  • Giuseppe Mastrangelo,
  • Ugo Fedeli and ,
  • Cecilia Arici and
  • Stefano Porru
  • + 1 author+ 0 author

Introduction: Additional or better markers are needed to guide the clinical monitoring of patients with non-muscle-invasive bladder cancer (NMIBC). Aim: To investigate the influence of occupational exposures and genetic polymorphisms on recurrence an...

(This article belongs to the Section Occupational Safety and Health)
  • Article
  • Open Access
20 Citations
4,230 Views
20 Pages

Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance

  • Yun-Gil Roh,
  • Jeong-Yeon Mun,
  • Seon-Kyu Kim,
  • Won Young Park and ,
  • Mi-So Jeong,
  • Tae Nam Kim,
  • Won-Tae Kim,
  • Yung Hyun Choi,
  • In-Sun Chu and
  • Sun-Hee Leem
  • + 5 authors+ 0 author

30 May 2020

Although the 5-year survival rate of patients diagnosed with nonmuscle invasive bladder cancer (NMIBC) has reached 85%, more than 50% of patients suffer from frequent recurrences. To identify molecular targets associated with recurrence of NMIBC, we...

  • Article
  • Open Access
24 Citations
3,668 Views
13 Pages

The Predictive Value of Systemic Immune-Inflammation Index on Bladder Recurrence on Upper Tract Urothelial Carcinoma Outcomes after Radical Nephroureterectomy

  • Tsu-Ming Chien,
  • Ching-Chia Li,
  • Yen-Man Lu,
  • Yii-Her Chou and ,
  • Hsueh-Wei Chang and
  • Wen-Jeng Wu
  • + 1 author+ 0 author

12 November 2021

Background: This study aimed to assess the prognostic significance of pre-treatment lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma (UTUC) patients. Methods: This study included non-metastatic UTUC patients tre...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
133 Views
15 Pages

Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with Adverse Histology and 12-Month Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer

  • Dragoș Florin Vasile,
  • Mihnea Meșină,
  • George G. Mitroi,
  • Alexandru-Daniel Danilă and ,
  • Cosmin Vasile Obleaga,
  • Mihai Alexandru Radu,
  • Georgică Târtea and
  • George F. Mitroi
  • + 3 authors+ 0 author

2 November 2026

Background/Objectives: Non-muscle-invasive bladder cancer (NMIBC) recurs frequently, and clinicopathological tools predict recurrence imperfectly. We assessed whether six preoperative blood-count-derived inflammatory indices (SII, SIRI, PIV, NLR, PLR...

(This article belongs to the Special Issue Bladder Cancer: Diagnosis and Treatments)
  • Article
  • Open Access
32 Citations
4,231 Views
10 Pages

Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method

  • Makito Miyake,
  • Nobutaka Nishimura,
  • Yasushi Nakai,
  • Tomomi Fujii and ,
  • Takuya Owari,
  • Shunta Hori,
  • Yosuke Morizawa,
  • Daisuke Gotoh,
  • Satoshi Anai and
  • Kiyohide Fujimoto
  • + 8 authors+ 3 authors

Clinical evidence regarding risk reduction of repeated bladder recurrence after initial photodynamic diagnosis (PDD)-assisted transurethral resection of bladder tumor (TURBT) is still limited in patients with non-muscle-invasive bladder cancer (NMIBC...

(This article belongs to the Special Issue Early Detection, Diagnosis, and Management of Bladder Cancer – Importance of Biomarkers)
  • Article
  • Open Access
6 Citations
4,900 Views
11 Pages

22 December 2022

(1) Background: This study investigates the early evaluation value of magnetic resonance imaging (MRI) and multidetector computed tomography (MDCT) in diagnosing the recurrence of bladder cancer (BC) after trans-urethral resection (TUR) alone or comb...

(This article belongs to the Section Cancer Imaging)
  • Systematic Review
  • Open Access
14 Citations
8,736 Views
19 Pages

10 December 2024

Background: Non-muscle-invasive bladder cancer (NMIBC) comprises about 75% of all bladder cancers. Although NMIBC is treatable, it poses significant costs and burdens to patients due to high recurrence rates. We conducted an updated meta-analysis of...

(This article belongs to the Special Issue Systematic Reviews and Meta-Analyses of Genitourinary Cancers)
  • Article
  • Open Access
1 Citations
1,602 Views
15 Pages

BLOSSOM Dietary Habits and 1-Year Intravesical Recurrence in High-Risk Non-Muscle-Invasive Bladder Cancer Treated with BCG

  • Carlo Buonerba,
  • Raffaele Baio,
  • Felice Crocetto,
  • Dario Bruzzese and ,
  • Francesco Del Giudice,
  • Antonio Nacchia,
  • Francesco Chiancone,
  • Concetta Ingenito,
  • Oriana Strianese and
  • Giuseppe Di Lorenzo
  • + 29 authors+ 24 authors

22 February 2026

Evidence on modifiable post-diagnosis factors influencing outcomes after intravesical Bacillus Calmette–Guérin (BCG) therapy for high-risk non-muscle-invasive bladder cancer (NMIBC) is limited. In this exploratory, feasibility-focused pr...

(This article belongs to the Section Genitourinary Oncology)
  • Article
  • Open Access
742 Views
12 Pages

The Burden of Worry: Fear of Cancer Recurrence Across Bladder Cancer Survivorship Phases—A Cross-Sectional Analysis

  • Dor Golomb,
  • Sébastien Simard,
  • Alon Eisner,
  • Yuval Avda and ,
  • Fahed Atamna and
  • Orit Raz
  • + 1 author+ 0 author

19 April 2026

Objective: To characterize the distribution of FCR severity across survivorship time intervals in bladder cancer survivors. Methods: A cross-sectional study of 79 patients utilized the validated 9-item FCR Inventory-Short Form (FCRI-SF) to assess ove...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
3 Citations
2,352 Views
13 Pages

Relationship between Preoperative Pyuria and Bacille Calmette-Guerin Treatment in Intravesical Recurrence after Transurethral Resection of High-Risk, Non-Muscle Invasive, Bladder Carcinoma: A Retrospective Study of Human Data

  • Ryo Tsukamoto,
  • Tomokazu Sazuka,
  • Yoshinori Hattori,
  • Hiroaki Sato and ,
  • Takayuki Arai,
  • Yusuke Goto,
  • Yusuke Imamura,
  • Shinichi Sakamoto and
  • Tomohiko Ichikawa
  • + 4 authors+ 0 author

7 March 2023

Some researchers have found that preoperative pyuria is a risk factor for recurrence after transurethral resection of high-risk non-muscle invasive bladder cancer. However, to our knowledge, none have clarified the risks associated with pyuria accord...

  • Article
  • Open Access
6 Citations
2,672 Views
13 Pages

Circulating Forms of Urokinase-Type Plasminogen Activator Receptor in Plasma Can Predict Recurrence and Survival in Patients with Urothelial Carcinoma of the Bladder

  • Line H. Dohn,
  • Peter Thind,
  • Lisbeth Salling,
  • Henriette Lindberg and ,
  • Sofie Oersted,
  • Ib J. Christensen,
  • Ole D. Laerum,
  • Martin Illemann,
  • Hans von der Maase and
  • Helle Pappot
  • + 6 authors+ 1 author

14 May 2021

Urothelial carcinoma of the bladder is a highly aggressive disease characterised by a very heterogeneous clinical outcome. Despite cystectomy, patients still have a high recurrence risk and shortened survival. Urokinase-type plasminogen activator rec...

(This article belongs to the Special Issue Systemic Treatment of Advanced Bladder Cancer – Status Update)
  • Article
  • Open Access
19 Citations
3,652 Views
15 Pages

26 April 2024

The currently available EORTC, CUETO and EAU2021 risk stratifications were originally developed to predict recurrence and progression in non-muscle-invasive bladder cancer (NMIBC). However, they have not been validated to differentiate between high-g...

(This article belongs to the Special Issue Prognostic Factors in Urologic Cancers—Assessment and Integration into Clinical Care)
  • Article
  • Open Access
7 Citations
4,322 Views
19 Pages

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups

  • Xuan-Mei Piao,
  • Seon-Kyu Kim,
  • Young Joon Byun,
  • Chuang-Ming Zheng and ,
  • Ho Won Kang,
  • Won Tae Kim,
  • Yong-June Kim,
  • Sang-Cheol Lee,
  • Wun-Jae Kim and
  • Seok Joong Yun
  • + 7 authors+ 2 authors

21 November 2022

To evaluate the utility of different risk assessments in non-muscle-invasive bladder cancer (NMIBC) patients, a total of 178 NMIBC patients from Chungbuk National University Hospital (CBNUH) were enrolled, and the predictive value of the molecular si...

(This article belongs to the Section Molecular Oncology)
  • Article
  • Open Access
14 Citations
3,456 Views
9 Pages

Tumor Multifocality is a Significant Risk Factor of Urinary Bladder Recurrence after Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma: A Single-Institutional Study

  • Chuan-Shu Chen,
  • Jian-Ri Li,
  • Shian-Shiang Wang,
  • Cheng-Kuang Yang and ,
  • Chen-Li Cheng,
  • Chi-Rei Yang,
  • Yen-Chuan Ou,
  • Hao-Chung Ho,
  • Chia-Yen Lin and
  • Shun-Fa Yang
  • + 9 authors+ 4 authors

The purpose of this study was to identify the significant risk factors of urinary bladder recurrence (UBR) after nephroureterectomy (NUx) in patients with upper tract urothelial carcinoma (UTUC). A total of 550 patients diagnosed with UTUC between Ja...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Systematic Review
  • Open Access
29 Citations
7,313 Views
25 Pages

Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis

  • Francesco Del Giudice,
  • Vincenzo Asero,
  • Eugenio Bologna,
  • Carlo Maria Scornajenghi and ,
  • Dalila Carino,
  • Virginia Dolci,
  • Pietro Viscuso,
  • Stefano Salciccia,
  • Alessandro Sciarra and
  • Ettore De Berardinis
  • + 33 authors+ 28 authors

23 March 2023

Background: In an era of Bacillus of Calmette-Guérin (BCG) shortages, the comparative efficacy from different adjuvant intravesical BCG strains in non-muscle invasive bladder cancer (NMIBC) has not been clearly elucidated. We aim to compare, t...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
24 Citations
4,885 Views
14 Pages

Urinary Metabolic Signatures Detect Recurrences in Non-Muscle Invasive Bladder Cancer

  • Alba Loras,
  • M. Carmen Martínez-Bisbal,
  • Guillermo Quintás,
  • Salvador Gil and ,
  • Ramón Martínez-Máñez and
  • José Luis Ruiz-Cerdá
  • + 1 author+ 0 author

29 June 2019

Patients with non-muscle invasive bladder cancer (NMIBC) undergo lifelong monitoring based on repeated cystoscopy and urinary cytology due to the high recurrence rate of this tumor. Nevertheless, these techniques have some drawbacks, namely, low accu...

(This article belongs to the Special Issue New Biomarkers in Cancers)
  • Review
  • Open Access
8 Citations
8,763 Views
23 Pages

Upper tract urothelial carcinoma (UTUC) is a relatively rare, but highly malignant, disease with an estimated annual incidence of 2 cases per 100,000 people. The main surgical treatment modalities for UTUC are radical nephroureterectomy (RNU) with bl...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
11 Citations
5,325 Views
20 Pages

How Cancer Cells Invade Bladder Epithelium and Form Tumors: The Mouse Bladder Tumor Model as a Model of Tumor Recurrence in Patients

  • Andreja Erman,
  • Urška Kamenšek,
  • Urška Dragin Jerman,
  • Mojca Pavlin and ,
  • Maja Čemažar,
  • Peter Veranič and
  • Rok Romih
  • + 2 authors+ 0 author

Non-muscle-invasive bladder cancer is the most common form of bladder cancer. The main problem in managing bladder tumors is the high recurrence after the transurethral resection of bladder tumors (TURBT). Our study aimed to examine the fate of intra...

(This article belongs to the Special Issue Bladder Cancer)
  • Article
  • Open Access
29 Citations
6,701 Views
14 Pages

Gardnerella vaginalis in Recurrent Urinary Tract Infection Is Associated with Dysbiosis of the Bladder Microbiome

  • Jeong-Ju Yoo,
  • Ju Sun Song,
  • Woong Bin Kim,
  • Jina Yun and ,
  • Hee Bong Shin,
  • Mi-Ae Jang,
  • Chang Beom Ryu,
  • Sung Shin Kim,
  • Jun Chul Chung and
  • on behalf of the SMS (Soonchunhyang Microbiome Multi-Disciplinary Study Group)
  • + 14 authors+ 9 authors

20 April 2022

Recent studies on the urine microbiome have highlighted the importance of the gut–vagina–bladder axis in recurrent urinary tract infection (rUTI). In particular, the role of Gardnerella as a covert pathogen that activates E. coli in anima...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
4 Citations
2,325 Views
12 Pages

Somatic Mutation of the Non-Muscle-Invasive Bladder Cancer Associated with Early Recurrence

  • Seong Hyeon Yu,
  • Sung Sun Kim,
  • Hyungki Lee,
  • Shinseung Kim and
  • Taek Won Kang

13 October 2023

Next-generation sequencing (NGS) is widely used in muscle-invasive bladder cancer but has limited use in non-muscle-invasive bladder cancer (NMIBC) due to significant heterogeneity and high cancer-specific survival. Therefore, we evaluated the genomi...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
8 Citations
4,987 Views
10 Pages

A Comparison of the Anesthetic Methods for Recurrence Rates of Bladder Cancer after Transurethral Resection of Bladder Tumors Using National Health Insurance Claims Data of South Korea

  • Sang Won Lee,
  • Bum Sik Tae,
  • Yoon Ji Choi,
  • Sang Min Yoon and ,
  • Yoon Sook Lee,
  • Jae Hwan Kim,
  • Hye Won Shin,
  • Jae Young Park and
  • Jae Hyun Bae
  • + 4 authors+ 0 author

21 February 2022

Bladder cancers have high recurrence rates and are usually removed via transurethral resection of bladder tumor (TURBT). Recently, some reports showed that the anesthetic method may affect the recurrence rates of bladder cancers. The purpose of this...

(This article belongs to the Special Issue General and Regional Anesthesia during Perioperative Period)
  • Article
  • Open Access
8 Citations
2,450 Views
15 Pages

CD4, CD20 and PD-L1 as Markers of Recurrence in Non-Muscle-Invasive Bladder Cancer

  • Aleksandra Semeniuk-Wojtaś,
  • Magdalena Modzelewska,
  • Karolina Poddębniak-Strama,
  • Sylwia Kołaczyńska and ,
  • Arkadiusz Lubas,
  • Barbara Górnicka,
  • Anna Jakieła and
  • Rafał Stec
  • + 3 authors+ 0 author

22 November 2023

Introduction: A tumor microenvironment plays an important role in bladder cancer development and in treatment response. Purpose: The aim of the study was to assess how the components of the microenvironment affect tumor recurrence and to find the pot...

  • Article
  • Open Access
513 Views
12 Pages

Prediagnostic Urinary Tract-Related Manifestations and Recurrence Risk in Colorectal Cancer with Bladder Involvement

  • Yi-Huei Chang,
  • Yi-Chang Chen,
  • Wen-Chi Chen,
  • Tao-Wei Ke and ,
  • Chi-Ping Huang,
  • Laing-You Wu,
  • Hui-Tsung Hsu and
  • Chi-Jung Chung
  • + 3 authors+ 0 author

27 July 2026

Background/Objectives: Colorectal cancer (CRC) with bladder involvement represents a distinct subgroup of locally advanced disease frequently accompanied by urinary tract-related manifestations (UTRMs). However, the clinical relevance of prediagnosti...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
7 Citations
5,282 Views
11 Pages

Introduction: A subset of interstitial cystitis/bladder pain syndrome (IC/BPS) patients experience recurrent urinary tract infection (rUTI) associated with symptom flares. Recurrent UTI subjects with associated IC/BPS were enrolled in the first North...

(This article belongs to the Section Bacterial Pathogens)
  • Article
  • Open Access
1 Citations
1,653 Views
15 Pages

Prognostic Value of the De Ritis Ratio in Predicting Survival After Bladder Recurrence Following Nephroureterectomy for Upper Urinary Tract Tumors

  • Enis Mert Yorulmaz,
  • Kursad Donmez,
  • Serkan Ozcan,
  • Osman Kose and ,
  • Sacit Nuri Gorgel,
  • Enes Candemir and
  • Yigit Akin
  • + 2 authors+ 0 author

Background/Objectives: Upper tract urothelial carcinoma (UTUC) is often complicated by intravesical recurrence and cancer progression following radical nephroureterectomy (RNU). Identifying reliable prognostic biomarkers remains crucial for optimizin...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
5 Citations
3,965 Views
10 Pages

Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer

  • Lukas Scheipner,
  • Hanna Zurl,
  • Julia V. Altziebler,
  • Georg P. Pichler and ,
  • Stephanie Schöpfer-Schwab,
  • Samra Jasarevic,
  • Michael Gaisl,
  • Klara C. Pohl,
  • Karl Pemberger and
  • Johannes Mischinger
  • + 13 authors+ 8 authors

8 December 2023

Purpose: To test the association between the Charlson–Deyo Comorbidity Index (CCI) and the recurrence of non-muscle-invasive bladder cancer (NMIBC). Methods: NMIBC (Ta, T1, TIS) patients who underwent transurethral resection of bladder tumor (T...

(This article belongs to the Special Issue Clinical Outcomes in Urologic Cancers)
  • Review
  • Open Access
34 Citations
7,230 Views
34 Pages

Predicting Recurrence of Non-Muscle-Invasive Bladder Cancer: Current Techniques and Future Trends

  • Aya T. Shalata,
  • Mohamed Shehata,
  • Eric Van Bogaert,
  • Khadiga M. Ali and ,
  • Ahmed Alksas,
  • Ali Mahmoud,
  • Eman M. El-Gendy,
  • Mohamed A. Mohamed,
  • Guruprasad A. Giridharan and
  • Ayman El-Baz
  • + 6 authors+ 1 author

14 October 2022

Bladder cancer (BC) is the 10th most common cancer globally and has a high mortality rate if not detected early and treated promptly. Non-muscle-invasive BC (NMIBC) is a subclassification of BC associated with high rates of recurrence and progression...

  • Article
  • Open Access
2 Citations
1,180 Views
7 Pages

14 May 2021

Objectives: We aimed to study the incidence and predictors of upper tract urothelial cancer (UTUC) in patients with high-risk non-muscle invasive bladder cancer (HR-NMIBC). Methods: Patients who had HR-NMIBC were reviewed to identify t...

  • Article
  • Open Access
18 Citations
3,824 Views
11 Pages

30 March 2023

Current treatment for non-muscle invasive bladder cancer (NMIBC) is the conventional transurethral resection of bladder tumor (CTURBT), but the en bloc transurethral resection of bladder tumor (ERBT) has been gaining more attraction in recent years c...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
1 Citations
934 Views
14 Pages

Immunosuppressive Role of Integrin β8 in Recurrence After Bacillus Calmette–Guérin (BCG) Therapy for Non-Muscle Invasive Bladder Cancer

  • Seiji Hoshi,
  • Satoru Meguro,
  • Syunta Makabe,
  • Akifumi Onagi and ,
  • Emina Kayama,
  • Kei Yaginuma,
  • Hitomi Imai,
  • Ryo Tanji,
  • Ruriko Honda-Takinami and
  • Yoshiyuki Kojima
  • + 11 authors+ 6 authors

12 December 2025

Background: Although immunosuppressive factors contribute to the recurrence of non-muscle invasive bladder cancer (NMIBC) during Bacillus Calmette–Guérin (BCG) therapy, the mechanism remains unclear. Methods: In this study, key players i...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
12 Citations
6,206 Views
11 Pages

Copy Number Analysis of 24 Oncogenes: MDM4 Identified as a Putative Marker for Low Recurrence Risk in Non Muscle Invasive Bladder Cancer

  • Samanta Salvi,
  • Daniele Calistri,
  • Giorgia Gurioli,
  • Elisa Carretta and ,
  • Luigi Serra,
  • Roberta Gunelli,
  • Wainer Zoli and
  • Valentina Casadio
  • + 3 authors+ 0 author

14 July 2014

Patients with non-muscle invasive bladder cancer (NMIBC) generally have a high risk of relapsing locally after primary tumor resection. The search for new predictive markers of local recurrence thus represents an important goal for the management of...

(This article belongs to the Special Issue Molecular Research in Urology 2014)
  • Article
  • Open Access
18 Citations
4,571 Views
26 Pages

Protein Biomarker Discovery Studies on Urinary sEV Fractions Separated with UF-SEC for the First Diagnosis and Detection of Recurrence in Bladder Cancer Patients

  • Stephanie Jordaens,
  • Eline Oeyen,
  • Hanny Willems,
  • Filip Ameye and ,
  • Stefan De Wachter,
  • Patrick Pauwels and
  • Inge Mertens
  • + 2 authors+ 0 author

Urinary extracellular vesicles (EVs) are an attractive source of bladder cancer biomarkers. Here, a protein biomarker discovery study was performed on the protein content of small urinary EVs (sEVs) to identify possible biomarkers for the primary dia...

(This article belongs to the Special Issue The Next Generation of Proteomics for Precision Medicine)
  • Article
  • Open Access
191 Views
16 Pages

1 November 2026

Objectives: This study aimed to evaluate lamina propria invasion in pT1 bladder urothelial carcinoma using different substaging methods and to compare the relationships of these methods with recurrence and progression. Methods: In 140 retrospectively...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
1 Citations
878 Views
9 Pages

De-Intensification Strategies in Non-Muscle-Invasive Bladder Cancer: Outcomes and Cost Impact of In-Office Bladder Fulguration

  • Maria Teresa Melgarejo Segura,
  • Miguel Herraez Marcos,
  • Maria Carmen Cano Garcia,
  • Alberto Zambudio Munuera and ,
  • Patricia Rodriguez Parras and
  • Miguel Angel Arrabal Polo
  • + 1 author+ 0 author

4 March 2026

Background/Objectives: Non-muscle invasive bladder cancer (NMIBC) is characterized by high recurrence rates, requiring frequent diagnostic and therapeutic interventions. This study evaluates the feasibility, safety, oncological outcomes, and economic...

(This article belongs to the Special Issue The Importance of Advances in Urological Surgery: From Open Surgery to Minimally Invasive Surgery)
  • Review
  • Open Access
2 Citations
1,804 Views
26 Pages

Rationale and Emerging Evidence on the Potential Role of HoLEP-Mediated Relief of Bladder Outlet Obstruction in NMIBC Outcomes Through Optimal Management of Chronic Urinary Retention

  • Angelo Porreca,
  • Filippo Marino,
  • Davide De Marchi,
  • Marco Giampaoli and ,
  • Daniele D’Agostino,
  • Francesca Simonetti,
  • Mauro Ragonese,
  • Antonio Amodeo,
  • Paolo Corsi and
  • Luca Di Gianfrancesco
  • + 6 authors+ 1 author

1 December 2025

Background: Non-muscle-invasive bladder cancer (NMIBC) represents approximately 70–75% of newly diagnosed bladder cancers and is characterized by high recurrence rates despite guideline-based management. Chronic urinary retention and bladder ou...

(This article belongs to the Section Clinical Research in Cancer)
  • Article
  • Open Access
13 Citations
8,251 Views
13 Pages

24 January 2018

A colorimetric microarray for the multiplexed detection of recurrence of bladder cancer including protein markers interleukin-8 (IL8), decorin (DCN), and vascular endothelial growth factor (VEGF) was established to enable easy and cheap read-out by a...

(This article belongs to the Special Issue Biomarkers)
  • Article
  • Open Access
5 Citations
3,017 Views
13 Pages

Predictive Molecular Biomarkers of Bladder Cancer Identified by Next-Generation Sequencing—Preliminary Data

  • Aleksander Myszka,
  • Marek Ciesla,
  • Aleksandra Siekierzynska,
  • Anna Sendera and ,
  • Constantina Constantinou,
  • Pawel Karpinski,
  • Grzegorz Wysiadecki and
  • Krzysztof Balawender
  • + 3 authors+ 0 author

17 December 2024

Background: The majority of patients with bladder cancer suffer from tumour recurrence. Identifying prognostic factors for tumour recurrence is crucial for treatment and follow-up in affected patients. The study aimed to assess the impact of somatic...

(This article belongs to the Section Oncology)
  • Article
  • Open Access
10 Citations
7,027 Views
10 Pages

Intravesical Prostatic Protrusion and Prognosis of Non-Muscle Invasive Bladder Cancer: Analysis of Long-Term Data over 5 Years with Machine-Learning Algorithms

  • Junghoon Lee,
  • Min Soo Choo,
  • Sangjun Yoo,
  • Min Chul Cho and ,
  • Hwancheol Son and
  • Hyeon Jeong
  • + 1 author+ 0 author

20 September 2021

We aim to investigate the significance of intravesical prostate protrusion (IPP) on the prognosis of non-muscle invasive bladder cancer (NMIBC) after the transurethral resection of bladder tumors (TURBT). For newly diagnosed NMIBC, we retrospectively...

(This article belongs to the Special Issue Advances in Management of Bladder Cancer)
  • Article
  • Open Access
1 Citations
1,391 Views
14 Pages

23 March 2026

Background/Objectives: Early recurrence after complete initial transurethral resection of bladder tumor (TUR-BT) may indicate biologically aggressive non-muscle-invasive bladder cancer (NMIBC). This study aimed to identify clinicopathological predict...

(This article belongs to the Special Issue Bladder Cancer: Diagnosis and Treatments)
  • Review
  • Open Access
2,350 Views
25 Pages

Potential Target Line, FGFR3, EGFR and Immune Checkpoint Axis for Bladder Cancer Therapy

  • Akshayaa Manikandan,
  • Charles Emmanuel Jebaraj Walter,
  • Sankari Durairajan,
  • Natarajan Kumaresan and ,
  • Anandan Balakrishnan,
  • Ashwini Saravanan,
  • Jezra Emmanuel Walter and
  • Thanka Johnson
  • + 3 authors+ 0 author

25 May 2026

Bladder cancer worldwide has seen a sharp rise, making it a significant global health concern. Recurrence monitoring is the main concern in treating the disease, and drug resistance follows suit. Treatment options include first-line medications, adju...

(This article belongs to the Section Cancer Immunology and Immunotherapy)
  • Article
  • Open Access
6 Citations
3,197 Views
11 Pages

Is CIS a Contraindication to Hyperthermic Intravesical Chemotherapy (HIVEC) after BCG-Failure?

  • Vassili Anastay,
  • Michael Baboudjian,
  • Alexandra Masson-Lecomte,
  • Cédric Lebacle and ,
  • Alexandre Chamouni,
  • Jacques Irani,
  • Xavier Tillou,
  • Thibaut Waeckel,
  • Arnaud Monges and
  • Géraldine Pignot
  • + 9 authors+ 4 authors

24 February 2023

CIS of the bladder is associated with a high risk of progression. In the case of BCG failure, radical cystectomy should be performed. For patients who refuse or are ineligible, bladder-sparing alternatives are evaluated. This study aims to investigat...

(This article belongs to the Collection Hyperthermia in Cancer Therapy)

of 14